Interim Report Perbio Science AB January - March 2003
Interim report Perbio Science AB January - March 2003 Continued healthy sales growth although impacted by weak dollar · Net sales first quarter were SEK 518 (552) million, which was a decline of 6 percent. The decline is only an effect of the weak USD. In dollar terms sales increased 15 percent to USD 60.6 (52.8) million · Gross margin improved 46.1 percent (46.0 percent) · Profit after financial items first quarter was SEK 87 (95) million, which was a decline of 8 percent, but rose 13 percent measured in dollars to USD 10.2 (9.0) million impacted by higher insurance costs and depreciation · Profit after financial items was the groups highest ever in USD. · Earnings per share after full dilution down 8 percent to SEK 1.43 (1.56) Bioresearch Division · Sales up 5 percent in USD · Strong sales growth in Europe · Operating margin lower to 17.0 percent (19.5 percent) due to product mix, higher insurance costs, non-recurring license revenue 2002 and increased research and development spending · BSE-test (Mad Cow Disease) approved by the European Union Scientific Steering Committee Cell Culture Division · Sales up 16 percent in USD · BioProcess Containers (BPC) showed strong growth · Operating margin declined slightly to 16.6 percent (16.8 percent) due to higher insurance, depreciation costs and increased research and development spending Medical Device Division · Strong growth continues, sales up 22 percent · Operating margin up to 25.7 percent (22.5 percent) Information on Perbio Science CEO Leland Foster phone +1 435 757 6432 CFO Claes Wenthzel phone +46 42 26 90 92 or +46 70 862 01 22 More information on Perbio Science can be found on the company's website at www.perbio.com. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/04/28/20030428BIT00140/wkr0001.doc The full report http://www.waymaker.net/bitonline/2003/04/28/20030428BIT00140/wkr0002.pdf The full report